Figure 4.
Diagram illustrating the targeted therapies of IgAN based on the pathophysiology of IgAN. MMF = Mycophenolate Mofetil; CNIs = calcineurin inhibitors; TRF-Budenoside = Targeted-Release Formulation Budenoside; APRIL inhibitors = a proliferation-inducing ligand (APRIL) inhibitors; BAFF inhibitors = B-cell activation factor (BAFF) inhibitors.
